All Articles

How Proasis unlocks seamless data access to accelerate drug discovery

A glimpse into the future of AI and structure-based drug discovery

Why the future of structure-based drug discovery depends on better benchmarking for pose and activity prediction.

Exploring the structural and computational advances shaping the future of antibody therapies.

Artificial intelligence is rapidly redefining what’s possible in ligand design. In this article, we explore recent breakthroughs in AI in drug discovery and computational chemistry

Unlocking the power of decentralised data for drug discovery success